Navigation Links
International Study Confirms CNSystems-Technology

GRAZ, Austria, September 30, 2011 /PRNewswire/ --

The well-established high tech company CNSystems once again attracts international attention with a big mile stone. The Bordeaux University Hospital (France) confirms that the validated CNAP blood pressure wave offers the possibility of precise therapy control during surgery. Already today, the recently released product innovation CNAP-PPV, proves to be a sensational, noninvasive alternative solution to the standard high-risk procedures for monitoring the fluid status during operations.

CNAP-PPV is the noninvasive solution for the continuous monitoring of the patient's fluid status during surgery. With a simple double-finger cuff CNAP-PPV and, simultaneously, the blood pressure are measured for every single heartbeat.

This ingenious combination monitors blood pressure and fluid status without burdening the patient's body with risky, invasive procedures always requiring an arterial catheter.

The French team of Univ.-Prof. Matthieu Biais confirms in its scientific publication that the CNAP-PPV method perfectly shows the same outcome as the expensive and high-risk invasive procedures: "Our results suggest that in the operating room during vascular surgery, respiratory induced variations in the pulse pressure (PPV) measured non-invasively in the finger using the CNAP system correlate closely with the PPV measured invasively with an arterial catheter."

This brand new study emphasizes that the validated CNAP blood pressure wave allows for an accurate hemodynamic monitoring during operations. The increasing demand for risk-free and cost-saving solutions argue in favor of CNAP-PPV: "It is scientifically proven that fluid-optimization not only reduces patient risk but also shortens the duration of hospitalization.", says CNSystems-founder Dr. Juergen Fortin.

More than 86% of all US and 98% of all European intensive care specialists and anesthesiologists claim for improvements of hemodynamic monitoring as current technologies are not suitable for the full integration into the daily clinical routine.

The cost for CNAP-PPV only makes one-fifth compared to invasive methods. "This allows fluid-management to become a clinical standard in Anesthesia and can also be applied for minor-risk procedures.", explains Fortin.


Biais, M. et al. (2011). TheAbilityOfPulsePressureVariationsObtainedWithCNAP[TM]DeviceToPredictFluidResponsivenessInTheOperatingRoom. Anesthesia&Analgesia, 113(3), 523-8.

CNSystems from Austria is technological leader in noninvasive, continuous blood pressure measurement.

Alice Wellisch
CNSystems Medizintechnik AG
Tel: +43-316-723456-0


SOURCE CNSystems Medizintechnik AG
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
4. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
5. Yongye Biotechnology International Announces Second Quarter Results
6. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
9. Mindray Medical International Announces Second Quarter 2008 Results
10. Singapore to hold international pow-wow
11. Sangui BioTech International, Inc. Files Remaining Reports
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, Hungary, ... be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has ... it now. , Biomarkers are components in the blood, tissue or body ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:5/12/2016)... 2016 , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):